Insights from Vector Space
Insights, scenarios and models to help you understand how artificial intelligence
is transforming the way organisations work.
Nutraceutical claim compliance: the botanicals labyrinth and the 2025 NAS report
The 2025 NAS report: 45,762 inspections, EUR 197 million in seizures, 100 websites blocked for claims on supplements. The new AGCM regulation has been in force since November 2024, with sanctions up to EUR 10 million. The 2,000 botanicals claims "on hold" have been awaiting EFSA review since 2010. The 2024 CJEU ruling closed the grey area.
The Recruiter That Never Sleeps
By 2027, 75% of hiring processes will include AI proficiency tests. By 2028, one in four candidate profiles will be fake. AI is changing recruiting in ways that companies have not yet finished measuring.
Client Onboarding: The Work That AI Agents Are Taking Over
By 2029, agentic AI will resolve 80% of common customer service issues without human intervention. What changes in how companies onboard new clients, and why over 40% of projects will fail before reaching production.
Market access and AI in 2026: the 30,000-page JCA dossier
The EU HTA Regulation has been operational since January 12, 2025 for oncology and ATMPs. The Joint Clinical Assessment leads to dossiers of 10-30 PICOs per single product, up to 30,000 pages, with 90-100 days for submission. AIFA Resolution 88/2025 modernized the Italian framework, effective from April 1, 2026. AI for evidence synthesis is the constraint that decides who can sustain the pace.
Four GenAI Skills Every Worker Must Master
Gartner has identified the four generative AI skills that workers must develop in 2025: recognizing use cases, understanding the technology, writing effective prompts, and evaluating results. A practical guide for CIOs and HR leaders.
Approved Email in pharma: the loop worth 30% in prescriptions
Veeva HCP 360 2025: syncing an Approved Email within ten days of a visit increases the probability of prescription by 30%. 65% of HCP interactions are not synchronized. MLR review remains at 20 days in Europe and 50-60 in the United States. Indegene NEXT MLR Automation cuts the cycle by 30-50%.
Adopting GenAI Without Risk: The Personas and Landing Zone Method
Adopting GenAI without exposing sensitive data is possible with a structured approach based on risk personas and cloud landing zones. A practical guide for infrastructure and IT operations leaders.
Who Is Winning the Market for Business Process Automation Tools
Camunda and IBM are positioned in the Customers' Choice quadrant for BPA tools. An analysis of peer reviews to guide decisions in a market where automation and GenAI are changing the evaluation criteria.
GenAI in Finance Is Still in Pilot Mode. What Comes Next?
GenAI in finance: adoption doubled in one year but still stuck at the pilot stage. 63% of CFOs are optimistic about future value, but organizations are deliberately slowing spending to align with governance and risk management.
Veterinary clinic consolidation: Italy is the next hunting ground
IVC Evidensia operates more than 2,500 clinics in 20 countries. Mars Veterinary Health 3,000 facilities and 70,000 employees. AniCura 450 facilities in 14 European countries. In Italy AniCura has only 14 clinics, AVELIA was founded in 2024 as an Italian network. Italian consolidation will accelerate over the next 24-36 months under the push of Northern European private equity.
Cloud ERP, Reporting Automation, and AI: The Three Priorities of the Modern CFO
Cloud ERP, reporting automation, and business process automation are the technologies with the best combined profile of adoption, value, and future investment for CFOs in 2026. Data and analysis from the Finance Technology Bullseye.
GenAI and Finance: Where Investments Are Heading
The Finance Technology Bullseye 2026 analyzes 63 technologies across adoption, value, and future investment. GenAI is the number one priority, but most organizations are still in the pilot phase. Here is the complete map.
